Luye Pharma Group Ltd (LUP) — Cash Flow Reinvestment Rate
Luye Pharma Group Ltd (LUP) has a Cash Flow Reinvestment Rate of 0.52x as of June 2023, reinvesting €180.80 Million (capex €0.00 plus investments €180.80 Million) from operating cash flow of €344.86 Million. Explore Luye Pharma Group Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Luye Pharma Group Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Luye Pharma Group Ltd across 10 annual periods. Also explore balance sheet size of Luye Pharma Group Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Luye Pharma Group Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Luye Pharma Group Ltd. For live market cap and broader valuation context, see Luye Pharma Group Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.03x | €3.62 Billion | €1.78 Billion | €1.00 Billion | ▼ -88.2% |
| 2024 | 17.16x | €2.88 Billion | €167.76 Million | €1.71 Billion | ▲ +1246.2% |
| 2023 | 1.27x | €2.03 Billion | €1.60 Billion | €1.17 Billion | ▼ -25.3% |
| 2022 | 1.71x | €2.82 Billion | €1.65 Billion | €1.16 Billion | ▼ -88.1% |
| 2021 | 14.33x | €2.61 Billion | €182.37 Million | €556.20 Million | ▲ +645.0% |
| 2020 | 1.92x | €1.99 Billion | €1.03 Billion | €692.81 Million | ▲ +106.8% |
| 2019 | 0.93x | €1.32 Billion | €1.42 Billion | €999.34 Million | ▼ -26.5% |
| 2018 | 1.27x | €1.32 Billion | €1.05 Billion | €728.16 Million | ▲ +61.2% |
| 2017 | 0.78x | €756.56 Million | €964.10 Million | €507.32 Million | ▼ -78.4% |
| 2016 | 3.64x | €2.15 Billion | €592.03 Million | €319.14 Million | — |